PDF herunterladen
Nuklearmedizin 2018; 57(01): 1-3
DOI: 10.3413/Nukmed-0947-17-11
Editorial
Schattauer GmbH

Propranolol und Morbus Parkinson

Was der Nuklearmediziner über den β2-Adrenorezeptor und das α-Synuclein-Gen wissen sollte
Markus Dietlein
1   Klinik und Poliklinik für Nuklearmedizin, Universitätsklinikum Köln
,
Felix Dietlein
2   Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
,
Alexander Drzezga
1   Klinik und Poliklinik für Nuklearmedizin, Universitätsklinikum Köln
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received: 25. November 2017

accepted in revised form: 15. Dezember 2017

Publikationsdatum:
21. Februar 2018 (online)

Auch verfügbar auf
   Lizenzen und Reprints

 

 

  • Literatur

  • 1 Dietlein M, Grünwald F, Schmidt M, Schneider P, Verburg FA, Luster M. Verfahrensanweisung zur Radioiodtherapie bei gutartigen Schilddrüsenerkrankungen (Version 5). Nuklearmedizin 2016; 55: 213-220.
    Thieme ConnectPubMedSuche in Google Scholar
  • 2 Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL. et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 2016; 26: 1343-1421.
    CrossrefPubMedSuche in Google Scholar
  • 3 Mittal S, Bjornevik K, Im DS, Flierl A, Dong X, Locasio JJ. et al. β2-Adrenoreceptor is a regulator of the –synuclein gene driving risk of Parkinson’s disease. Science 2017; 357: 891-898.
    CrossrefPubMedSuche in Google Scholar
  • 4 Snyder EY. Finding a new purpose for old drugs. Drugs used for the treatment of asthma might prevent Parkinson’s disease. Science 2017; 357: 869-870.
    CrossrefPubMedSuche in Google Scholar
  • 5 Alves G, Müller B, Herlofson K, Hogen IEsch, Telstad W, Aarsland D. et al. Incidence of Parkinson’s disease in Norway: The Norwegian ParkWest study. J Neurol Neurosurg Psychiatry 2009; 80: 851-857.
    CrossrefPubMedSuche in Google Scholar
  • 6 Hughes KC, Gao X, Kim IY, Wang M, Weisskopf MG, Schwarzschild MA, Ascherio A. Intake of dairy foods and risk of Parkinson disease. Neurology 2017; 89: 46-52.
    CrossrefPubMedSuche in Google Scholar
  • 7 Park M, Ross GW, Petrovitch H. et al. Consumption of milk and calcium in midlife and the future risk of Parkinson disease. Neurology 2005; 64: 1047-1051.
    CrossrefPubMedSuche in Google Scholar
  • 8 Chen H, O’Reilly E, McCullough ML. et al. Consumption of dairy products and risk of Parkinson’s disease. Am J Epidemiol 2007; 165: 998-1006.
    CrossrefPubMedSuche in Google Scholar
  • 9 Saaksjarvi K, Knekt P, Lundqvist A. et al. A cohort study on diet and the risk of Parkinson’s disease: the role of food groups and diet quality. Br J Nutr 2013; 109: 329-337.
    CrossrefPubMedSuche in Google Scholar